F2G and Shionogi’s olorofim met its goals in a late-stage study, setting the stage for an FDA filing this year ...

The advance opens up potential therapeutic uses for clearing unwanted proteins ...

Mixing an electrochemically active cathode material powder (left) with a new fluorine-free binder (middle) and a nontoxic ...

Estuary Biotherapeutics, which is developing gene therapies to treat kidney disease, has launched with $103 million in ...

A ruthenium-based reaction exploits the stronger carbon-deuterium bond to enrich one mirror-image form from a racemic mixture ...

Max M. Hansmann, an organic chemist at the Technical University of Dortmund who also works on carbon-atom transfer reactions, ...

Heiner Linke, with his two hands raised in front of him, stands in front of a screen announcing that Henri Kagan and Kenso Soai have been awarded the Nobel Prize in Chemistry. Heiner Linke uses his ...

To refine rare earths, Alta’s engineers attach the proteins to chromatography resin that is used to separate the elements.

Finally, we should be worried about how these trial markets could impact public perception of the drug development and ...

Biotechs in the US and Europe face challenges, but as a recent panel discussion made clear, the competition offers global ...

The 2026 chemistry Nobel announcement sparked a frenzy of chirality fact-checking. Turns out, nailing stereochemistry is ...

In a recent related study, researchers in China also developed a heterogeneous hydroformylation catalyst based on rhodium.